From biotechnology to novel delivery systems, the ever-increasing complexity of new drugs provides major technical challenges for the pharmaceutical analyst. In this symposium, eight speakers from the pharmaceutical industry and from regulatory bodies in the United Kingdom (Medicines Control Agency) and the United States (Food and Drug Administration) identified and discussed key areas where analytical science continues to shape and be shaped by new regulations for registration of new drug preparations.
展开▼
